{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T07:18:49Z","timestamp":1770275929885,"version":"3.49.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,24]],"date-time":"2020-07-24T00:00:00Z","timestamp":1595548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,24]],"date-time":"2020-07-24T00:00:00Z","timestamp":1595548800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Vet Res"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>To evaluate the effect on arterial blood pressure (ABP) of labetalol infusion as treatment for perioperative non nociceptive acute hypertension in dogs. The clinical records of dogs receiving intra or postoperative labetalol infusion were retrospectively reviewed. Invasive systolic (SAP), mean (MAP) and diastolic (DAP) arterial pressure and heart rate (HR) before labetalol infusion (T0) and 15, 30, 45 and 60\u00a0min (T1, T2, T3 and T4 respectively) after infusion were retrieved. The dose rate of labetalol infusion and use of concurrently administered drugs that could have potentially affected ABP and\/or HR were also recorded. ANOVA for repeated measures and Dunnett\u2019s multiple comparison test were used to determine the effect of labetalol on ABP and HR. Differences were considered significant when<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 20 dogs met the inclusion criteria, and hypertension was documented after craniotomy (12\/20), adrenalectomy (4\/20) and other procedures (4\/20). Five dogs received labetalol intraoperatively, 14 postoperatively, and 1 during the surgical procedure and recovery. Median infusion duration and rate were 463 (60-2120) minutes and 1.1 (0.2\u20133.4) mg\/kg\/h respectively. Median loading dose was 0.2 (0.2\u20130.4) mg\/kg. Labetalol produced a significant decrease in SAP and DAP at all time points compared to T0 (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05), while the effect was not significant at T1 for MAP (<jats:italic>p<\/jats:italic>\u2009=\u20090.0519). Median maximum MAP decrease was 31 (20\u201390) mmHg. Heart rate did not increase significantly during treatment (<jats:italic>p<\/jats:italic>\u2009=\u20090.2454). Acepromazine given before or during labetalol treatment did not reduce significantly ABP (<jats:italic>p<\/jats:italic>\u2009=\u20090.735).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Labetalol produced a reliable and titratable decrease in ABP with non significant increase in HR.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12917-020-02475-4","type":"journal-article","created":{"date-parts":[[2020,7,24]],"date-time":"2020-07-24T07:02:31Z","timestamp":1595574151000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Retrospective evaluation of labetalol as antihypertensive agent in dogs"],"prefix":"10.1186","volume":"16","author":[{"given":"Francesco","family":"Zublena","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"De Gennaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Corletto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,24]]},"reference":[{"key":"2475_CR1","doi-asserted-by":"crossref","unstructured":"Collier JG, Dawnay NAH, Nachev CH, Robinson BF. Clinical investigation of an antagonist at \u03b1- and \u03b2- adrenoceptors \u2013 AH 5158. Br J Pharmac. 1972;44:286\u201393.","DOI":"10.1111\/j.1476-5381.1972.tb07265.x"},{"key":"2475_CR2","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1111\/j.1476-5381.1972.tb08125.x","volume":"45","author":"JB Farmer","year":"1972","unstructured":"Farmer JB, Kennedy I, Levy GP, Marshall RJ. Pharmacology of AH 5158; a drug which blocks both \u03b1- and \u03b2-adrenoceptors. Br J Pharmacology. 1972;45:660\u201375.","journal-title":"Br J Pharmacology"},{"key":"2475_CR3","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1161\/01.CIR.55.2.370","volume":"55","author":"J Mehta","year":"1977","unstructured":"Mehta J, Cohn JN. Hemodynamic effects of labetalol, an alpha and beta adrenergic blocking agent, in hypertensive subjects. Circulation. 1977;55:370\u20135.","journal-title":"Circulation"},{"key":"2475_CR4","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/j.1365-2125.1979.tb05917.x","volume":"8","author":"DA Richards","year":"1979","unstructured":"Richards DA, Prichard BNC. Clinical pharmacology of labetalol. Br J Clin Pharmac. 1979;8:89\u201393.","journal-title":"Br J Clin Pharmac"},{"key":"2475_CR5","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1111\/j.1365-2125.1976.tb00637.x","volume":"3","author":"DA Richards","year":"1976","unstructured":"Richards DA, Tuckman J, Prichard PNC. Assessment of \u03b1- and \u03b2-adrenoceptor blocking actions of labetalol. Br J Clin Pharmacol. 1976;3:849\u201355.","journal-title":"Br J Clin Pharmacol"},{"key":"2475_CR6","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/j.1476-5381.1980.tb07934.x","volume":"70","author":"RC Dage","year":"1980","unstructured":"Dage RC, Hsieh CP. Direct vasodilation by labetalol in anaesthetized dogs. Br J Pharmac. 1980;70:287\u201393.","journal-title":"Br J Pharmac"},{"key":"2475_CR7","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/j.1476-5381.1982.tb09275.x","volume":"77","author":"RT Brittain","year":"1982","unstructured":"Brittain RT, Drew GM, Levy GP. The \u03b1- and \u03b2- adrenoceptor blocking potencies of labetalol and its individual stereoisomers in anaesthetized dogs and in isolated tissues. Br J Pharmac. 1982;77:105\u201314.","journal-title":"Br J Pharmac"},{"key":"2475_CR8","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1111\/j.1476-5381.1991.tb12513.x","volume":"104","author":"E Riva","year":"1991","unstructured":"Riva E, Mennini T, Latini R. The \u03b1- and \u03b2-adrenoceptor blocking activities of labetalol and its RR-SR (50: 50) stereoisomers. Br J Pharmacol. 1991;104:823\u20138.","journal-title":"Br J Pharmacol"},{"key":"2475_CR9","doi-asserted-by":"publisher","first-page":"41S","DOI":"10.1111\/j.1365-2125.1982.tb01888.x","volume":"13","author":"BNC Prichard","year":"1982","unstructured":"Prichard BNC, Richards DA. Comparison of labetalol with other anti-hypertensive drugs. Br J Clin Pharmacol. 1982;13:41S\u201347S.","journal-title":"Br J Clin Pharmacol"},{"key":"2475_CR10","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1002\/clc.4960050202","volume":"5","author":"N Stern","year":"1982","unstructured":"Stern N, Teicher A, Rosenthal T. The treatment of hypertension by labetalol, a new alpha- and beta-adrenoreceptor blocking agent. Clin Cardiol. 1982;5:125\u201330.","journal-title":"Clin Cardiol"},{"key":"2475_CR11","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/clpt.1985.98","volume":"37","author":"M Lebel","year":"1985","unstructured":"Lebel M, Langlois S, Belleau LJ, Grose JH. Labetalol infusion in hypertensive emergencies. Clin Pharmacol Ther. 1985;37:615\u20138.","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"2475_CR12","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1097\/ANA.0b013e31806e5f5a","volume":"19","author":"G Magni","year":"2007","unstructured":"Magni G, La Rosa I, Gimignani S, Melillo G, Imperiale C, Rosa G. Early postoperative complications after intracranial surgery. J Neurosurg Anesthesiol. 2007;19(4):229\u201334.","journal-title":"J Neurosurg Anesthesiol"},{"issue":"1","key":"2475_CR13","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.4142\/jvs.2020.21.e8","volume":"21","author":"F Marquez Grados","year":"2020","unstructured":"Marquez Grados F, Vettorato E, Corletto F. Sevoflurane with opioid or dexmedetomidine infusions in dogs undergoing intracranial surgery: a retrospective observational study. J Vet Sci. 2020;21(1):e8.","journal-title":"J Vet Sci"},{"issue":"4","key":"2475_CR14","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1055\/s-0036-1592412","volume":"35","author":"NN Rabelo","year":"2016","unstructured":"Rabelo NN, Silveira Filho LJ, Santos dos Passos G, Araujo Dias Junior LA, Pereira CU, Araujo Dias LA, Figueiredo EG. Acute arterial hypertension in patients undergoing neurosurgery. Arq Bras Neurocir. 2016;35(4):296\u2013303.","journal-title":"Arq Bras Neurocir"},{"key":"2475_CR15","doi-asserted-by":"crossref","unstructured":"Olsen KS, Pedersen CB, Madsen JB, Ravn LI, Schifter S. Vasoactive modulators during and after craniotomy: relation to postoperative hypertension. J Neurosurg Anesthesiol. 2002 Jul;14(3):171\u20139.","DOI":"10.1097\/00008506-200207000-00001"},{"key":"2475_CR16","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1097\/00000542-200007000-00012","volume":"93","author":"A Basali","year":"2000","unstructured":"Basali A, Mascha EJ, Kalfas I, Schubert A. Relation between perioperative hypertension and intracranial hemorrhage after craniotomy. Anesthesiology. 2000;93:48\u201354.","journal-title":"Anesthesiology"},{"issue":"3","key":"2475_CR17","doi-asserted-by":"publisher","first-page":"317","DOI":"10.4103\/0970-9185.161665","volume":"31","author":"H Ramakrishna","year":"2015","unstructured":"Ramakrishna H. Pheochromocytoma resection: current concepts in anesthetic management. J Anaesthesiol Clin Pharmacol. 2015;31(3):317\u201323.","journal-title":"J Anaesthesiol Clin Pharmacol"},{"issue":"12","key":"2475_CR18","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.2460\/javma.242.12.1715","volume":"242","author":"JS Barrera","year":"2013","unstructured":"Barrera JS, Bernard F, Ehrhart EJ, Withrow SJ, Monnet E. Evaluation of risk factors for outcome associated with adrenal gland tumors with or without invasion of the caudal vena cava and treated via adrenalectomy in dogs: 86 cases (1993\u20132009). J Am Vet Med Assoc. 2013;242(12):1715\u201321.","journal-title":"J Am Vet Med Assoc"},{"key":"2475_CR19","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1111\/j.1939-1676.2008.0182.x","volume":"22","author":"MA Herrera","year":"2008","unstructured":"Herrera MA, Mehl ML, Kass PH, Pascoe PJ, Feldman EC, Nelson RW. Predictive factors and the effect of phenoxybenzamine on outcome in dogs undergoing adrenalectomy for pheochromocytoma. J Vet Intern Med. 2008;22:1333\u20139.","journal-title":"J Vet Intern Med"},{"key":"2475_CR20","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1093\/bja\/53.6.585","volume":"53","author":"C Gustafson","year":"1981","unstructured":"Gustafson C, Ahlgren I, Aronsen K-F, Rosberg B. Haemodynamic effects of labetalol-induced hypotension in the anaesthetized dog. Br J Anaesth. 1981;53:585\u201390.","journal-title":"Br J Anaesth"},{"key":"2475_CR21","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1111\/j.1399-6576.1982.tb01826.x","volume":"26","author":"H Van Aken","year":"1982","unstructured":"Van Aken H, Puchstein C, Schweppe ML, Heinecke A. Effect of labetalol on intracranial pressure in dogs with and without intracranial hypertension. Acta anaesthesiol Scand. 1982;26:615\u201319.","journal-title":"Acta anaesthesiol Scand"},{"issue":"S","key":"2475_CR22","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1017\/S096272860003178X","volume":"16","author":"J Reid","year":"2007","unstructured":"Reid J, Nolan AM, Hughes JML, Lascelles D, Pawson P, Scott EM. Development of the short-form Glasgow Composite Measure Pain Scale (CMPS-SF) and derivation of an analgesic intervention score. Anim Welf. 2007;16(S):97\u2013104.","journal-title":"Anim Welf"},{"key":"2475_CR23","doi-asserted-by":"crossref","unstructured":"Chambers D, Huang C, Matthews G. Arterial system. In: Chambers D, Huang C, Matthews G, editors. Basic physiology for anaesthetists, 2nd ed. Cambridge University Press; 2019. pp.\u00a0148\u201354.","DOI":"10.1017\/9781108565011"},{"issue":"4","key":"2475_CR24","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1177\/153857440403800409","volume":"38","author":"RH Samson","year":"2004","unstructured":"Samson RH. Periprocedural hypertension: current concepts in management for the vascular surgeon. Vasc Endovasc Sur. 2004;38(4):361\u20136.","journal-title":"Vasc Endovasc Sur"},{"key":"2475_CR25","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1213\/00000539-200208000-00003","volume":"95","author":"DL Reich","year":"2002","unstructured":"Reich DL, Bennett-Guerrero E, Bodian CA, Hossain S, Winfree W, Krol M. Intraoperative tachycardia and hypertension are independently associated with adverse outcome in noncardiac surgery of long duration. Anesth Analg. 2002;95:273\u20137.","journal-title":"Anesth Analg"},{"issue":"3","key":"2475_CR26","doi-asserted-by":"publisher","first-page":"615","DOI":"10.2147\/VHRM.S2471","volume":"4","author":"J Varon","year":"2008","unstructured":"Varon J, Marik PE. Perioperative hypertension management. Vasc Health Risk Manag. 2008;4(3):615\u201327.","journal-title":"Vasc Health Risk Manag"},{"issue":"19","key":"2475_CR27","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","volume":"289","author":"AV Chobanian","year":"2003","unstructured":"Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ, National High Blood Pressure Education Program Coordinating Committee. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003;289(19):2560\u201372.","journal-title":"JAMA"},{"key":"2475_CR28","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1136\/qshc.2002.004127","volume":"14","author":"AD Paix","year":"2005","unstructured":"Paix AD, Runciman WB, Horan BF, Chapman MJ, Currie M. Crisis management during anaesthesia: hypertension. Qual Saf Health Care. 2005;14:12\u20138.","journal-title":"Qual Saf Health Care"},{"key":"2475_CR29","doi-asserted-by":"publisher","first-page":"149","DOI":"10.5326\/JAAHA-MS-5868","volume":"49","author":"H Davis","year":"2013","unstructured":"Davis H, Jensen T, Johnson A, Knowles, Meyer R, Rucinsky R, Shafford H. 2013 AAHA\/AAFP fluid therapy guidelines for dogs and cats. J Am Anim Hosp Assoc. 2013;49:149\u201359.","journal-title":"J Am Anim Hosp Assoc"},{"key":"2475_CR30","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/j.1365-2125.1975.tb01564.x","volume":"2","author":"CB White","year":"1975","unstructured":"White CB, Udwadia BP. Beta-adrenoceptors on the human dorsal hand vein and the effects of propranolol and practolol on venous sensitivity to noradrenaline. Br J Clin Pharmacol. 1975;2:99\u2013105.","journal-title":"Br J Clin Pharmacol"},{"issue":"12","key":"2475_CR31","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1093\/cvr\/23.12.1043","volume":"23","author":"J Kedem","year":"1989","unstructured":"Kedem J, Sonn J, Scheinowitz M, Weiss HR. Relationship between local oxygen consumption and local and external cardiac work: effect of tachycardia. Cardiovasc Res. 1989;23(12):1043\u201352.","journal-title":"Cardiovasc Res"},{"key":"2475_CR32","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/j.1875-9114.1998.tb03924.x","volume":"18","author":"ME Goldberg","year":"1998","unstructured":"Goldberg ME, Larijani GE. Perioperative hypertension. Pharmacotherapy. 1998;18:911\u20134.","journal-title":"Pharmacotherapy"},{"issue":"1","key":"2475_CR33","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1097\/00000542-197807000-00008","volume":"49","author":"A Forster","year":"1978","unstructured":"Forster A, Van Horn K, Marshall LF, Shapiro HM. Anesthetic effects on blood-brain barrier function during acute arterial hypertension. Anesthesiology. 1978;49(1):26\u201330.","journal-title":"Anesthesiology"},{"issue":"1","key":"2475_CR34","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1161\/01.RES.39.1.33","volume":"39","author":"ET MacKenzie","year":"1976","unstructured":"MacKenzie ET, Strandgaard S, Graham DI, Jones JV, Harper AM, Farrar JK. Effects of acutely induced hypertension in cats on pial arteriolar caliber, local cerebral blood flow, and the blood-brain barrier. Circ Res. 1976;39(1):33\u201341.","journal-title":"Circ Res"},{"issue":"1","key":"2475_CR35","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1006\/exnr.1997.6756","volume":"150","author":"SC Fagan","year":"1998","unstructured":"Fagan SC, Bowes MP, Lyden PD, Zivin JA. Acute hypertension promotes hemorrhagic transformation in a rabbit embolic stroke model: effect of labetalol. Exp Neurol. 1998;150(1):153\u20138.","journal-title":"Exp Neurol"},{"issue":"2","key":"2475_CR36","doi-asserted-by":"publisher","first-page":"195S","DOI":"10.1111\/j.1365-2125.1979.tb04780.x","volume":"8","author":"RM Pearson","year":"1979","unstructured":"Pearson RM, Griffith DNM, Woollard M, James IM, Havard CWH. Comparison of effects on cerebral blood flow of rapid reduction in systemic arterial pressure by diazoxide and labetalol in hypertensive patients: preliminary findings. Br J Clin Pharmacol. 1979;8(2):195S\u2013198S.","journal-title":"Br J Clin Pharmacol"},{"key":"2475_CR37","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1093\/bja\/75.1.51","volume":"75","author":"KS Olsen","year":"1995","unstructured":"Olsen KS, Svendsen LB, Larsen FS, Paulson OB. Effect of labetalol on cerebral blood flow, oxygen metabolism and autoregulation in healthy humans. Br J Anaesth. 1995;75:51\u20134.","journal-title":"Br J Anaesth"},{"issue":"3","key":"2475_CR38","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1081\/PRG-120015845","volume":"21","author":"MA Belfort","year":"2002","unstructured":"Belfort MA, Tooke-Miller C, Allen JC Jr, Dizon-Townson D, Varner MA. Labetalol decreases cerebral perfusion pressures without negatively affecting cerebral blood flow in hypertensive gravidas. Hypertens Pregnancy. 2002;21(3):185\u201397.","journal-title":"Hypertens Pregnancy"},{"issue":"3","key":"2475_CR39","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1097\/00008506-200207000-00001","volume":"14","author":"KS Olsen","year":"2002","unstructured":"Olsen KS, Pedersen CB, Madsen JB, Ravn LI, Schifter S. Vasoactive modulators during and after craniotomy: relation to postoperative hypertension. J Neurosurg Anesthesiol. 2002;14(3):171\u20139.","journal-title":"J Neurosurg Anesthesiol"},{"key":"2475_CR40","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/BF01401430","volume":"67","author":"C Puchstein","year":"1983","unstructured":"Puchstein C, Van Aken H, Hidding J, Anger C, Lawin P. Treatment of hypertension with labetalol in neurosurgical practice. Influence of labetalol on cerebral perfusion pressure in dogs without and with intracranial mass lesions. Acta Neurochir (Wien). 1983;67:283\u201390.","journal-title":"Acta Neurochir (Wien)"},{"issue":"3","key":"2475_CR41","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1097\/00008506-199207000-00005","volume":"4","author":"M Dubois","year":"1992","unstructured":"Dubois M, Caputy A, MacCosbe P, Lea D, Duma C. Cerebral blood flow measurements during blood pressure control with intravenous labetalol following craniotomy. J Neurosurg Anesthesiol. 1992;4(3):176\u201381.","journal-title":"J Neurosurg Anesthesiol"},{"issue":"4","key":"2475_CR42","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1097\/00000539-200010000-00024","volume":"91","author":"RA Kross","year":"2000","unstructured":"Kross RA, Ferri E, Leung D, Pratila M, Broad C, Veronesi M, Melendez JA. A Comparative study between a calcium channel blocker (Nicardipine) and a combined \u03b1- \u03b2-blocker (Labetalol) for the control of emergence hypertension during craniotomy for tumor surgery. Anesth Analg. 2000;91(4):904\u20139.","journal-title":"Anesth Analg"},{"issue":"2","key":"2475_CR43","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1210\/jc.2009-1051","volume":"95","author":"H Bruynzeel","year":"2010","unstructured":"Bruynzeel H, Feelders RA, Groenland THN, van den Meiracker AH, van Eijck CHJ, Lange JF, de Herder WW, Kazemier G. Risk factors for hemodynamic instability during surgery for pheochromocytoma. J Clin Endocrinol Metab. 2010;95(2):678\u201385.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2475_CR44","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1093\/bjaed\/mkv033","volume":"16","author":"D Connor","year":"2016","unstructured":"Connor D, Boumphrey S. Perioperative care of phaeochromocytoma. BJA Educ. 2016;16(5):153\u20138. .","journal-title":"BJA Educ"},{"key":"2475_CR45","doi-asserted-by":"publisher","first-page":"229S","DOI":"10.1111\/j.1365-2125.1979.tb04786.x","volume":"8","author":"L Kaufman","year":"1979","unstructured":"Kaufman L. Use of labetalol during hypotensive anaesthesia and in the management of pheochromocytoma. Br J Clin Pharmac. 1979;8:229S\u2013232S.","journal-title":"Br J Clin Pharmac"},{"issue":"9","key":"2475_CR46","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1111\/j.1365-2044.1984.tb06611.x","volume":"39","author":"G Van Hasselt","year":"1984","unstructured":"Van Hasselt G, MacKenzie I, Edwards JC. Use of vecuronium and labetalol in patients with phaeochromocytoma. Anaesthesia. 1984;39(9):942\u20133.","journal-title":"Anaesthesia"},{"issue":"2","key":"2475_CR47","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1007\/BF03020487","volume":"49","author":"PC Chung","year":"2002","unstructured":"Chung PC, Li AH, Lin CC, Yang MW. Elevated vascular resistance after labetalol during resection of a pheochromocytoma (Brief report). Can J Anesth. 2002;49(2):148\u201350.","journal-title":"Can J Anesth"},{"issue":"8072","key":"2475_CR48","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/S0140-6736(78)90772-9","volume":"1","author":"RS Briggs","year":"1978","unstructured":"Briggs RS, Birtwell AJ, Pohl JE. Hypertensive response to labetalol in phaeochromocytoma. Lancet. 1978;1(8072):1045\u20136.","journal-title":"Lancet"},{"issue":"11","key":"2475_CR49","doi-asserted-by":"publisher","first-page":"4069","DOI":"10.1210\/jc.2007-1720","volume":"92","author":"K Pacak","year":"2007","unstructured":"Pacak K. Preoperative management of the pheochromocytoma patient. J Clin Endocrinol Metab. 2007;92(11):4069\u201379.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2475_CR50","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/vaa.12265","volume":"43","author":"ER Monteiro","year":"2016","unstructured":"Monteiro ER, Coelho K, Bressan TF, Simoes CR, Monteiro BS. Effects of acepromazine-morphine and acepromazine-methadone premedication on the minimum alveolar concentration of isoflurane in dogs. Vet Anaesth Analg. 2016;43(1):27\u20134.","journal-title":"Vet Anaesth Analg"},{"key":"2475_CR51","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1111\/j.1467-2995.2012.00766.x","volume":"39","author":"MD Sinclair","year":"2012","unstructured":"Sinclair MD, Dyson DH. The impact of acepromazine on the efficacy of crystalloid, dextran or ephedrine treatment in hypotensive dogs under isoflurane anesthesia. Vet Anaesth Analg. 2012;39:563\u201373.","journal-title":"Vet Anaesth Analg"}],"container-title":["BMC Veterinary Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-020-02475-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12917-020-02475-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-020-02475-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,10]],"date-time":"2024-08-10T18:26:33Z","timestamp":1723314393000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcvetres.biomedcentral.com\/articles\/10.1186\/s12917-020-02475-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,24]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2475"],"URL":"https:\/\/doi.org\/10.1186\/s12917-020-02475-4","relation":{},"ISSN":["1746-6148"],"issn-type":[{"value":"1746-6148","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,24]]},"assertion":[{"value":"29 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable, retrospective records review.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The datasets generated and\/or analysed during the current study are not publicly available due but are available from the corresponding author upon request.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and materials"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"256"}}